Aimei Health Technology Co., Ltd.

Aimei Health Technology Co., Ltd., trading on Nasdaq under the ticker AFJK, is a health technology company that completed its de-SPAC business combination with AF Acquisition Corp, a blank check company sponsored by AF Acquisition LLC that conducted its initial public offering in 2022. The combined entity operates in the healthcare technology sector with a focus on Asia-based markets. On August 13, 2026, the company filed a Form 10-Q quarterly report with the SEC, accession number 0001493152-26-037588, reflecting its current status as a reporting public company following the completion of its merger. Investors and analysts seeking comprehensive data on AFJK, including filing history, deal timelines, and peer benchmarking, can sign up for full access at SpacDesk.